Electronic Grant Submission

I enjoyed your recent article on electronic National Institutes of Health grant submission [L. Reif-Lehrer, The Scientist, April 3, 1995, page 1] and found the inset addressing computerized forms particularly interesting to me as a software developer. I am writing to alert you and your readers to our product, GrantSlam, which many investigators have found preferable to the options listed in the article's inset. GrantSlam is a Windows-based program dedicated to preparing NIH/Public Health Servi

Written byChristian Harker
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

GrantSlam is a Windows-based program dedicated to preparing NIH/Public Health Service grant applications using the PHS-398 and PHS-2590 forms. As medical researchers, we developed GrantSlam to be easy to use, to produce high-quality printouts, and to contain the functions and information we ourselves wanted in such a program. The result is that the electronic forms appear on screen just as they do on paper, and they serve as the front end for a database file structure. Data entry is quick and easy; all budgetary calculations are automatic and immediate. The output from a LaserJet III is virtually identical to original forms from PHS. We incorporated on-screen "Help" containing relevant sections of the PHS booklets and included additional Biosketch, Other Support, INRSA, and RCDA forms.

Since each investigator will want to choose his or her own word processor for preparing the body of the grant, we provide Continuation Page templates in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies